CVS Health forecasts higher revenue, maintains guidance, boosts dividend

WOONSOCKET, R.I. – Shares of CVS Health (NYSE:) Inc. saw an uptick of 3.9% Tuesday after the company confirmed its financial outlook for the current year and provided a revenue forecast for the upcoming year that exceeded expectations. The healthcare giant is projecting revenues close to $366 billion with an adjusted earnings per share (EPS) threshold of $8.50.

CVS Health, which is headquartered in Woonsocket, Rhode Island, has recently taken significant steps to enhance its business model and services. The company introduced CVS CostVantage and CVS Caremark TrueCost, both initiatives aimed at improving drug pricing transparency and reimbursement processes. As part of a broader rebranding effort, CVS also renamed its Health Services division to CVS Healthspire.

In addition to these strategic moves, CVS Health announced a dividend increase to 66.5 cents per share, marking a 10% hike. This dividend is scheduled to be paid on February 1st to shareholders on record as of January 22nd. This decision comes even as CVS’s stock has experienced a year-to-date decline of -26.5%, which stands in stark contrast to the S&P 500’s increase of +19%.

InvestingPro Insights

In light of CVS Health’s recent announcements, it’s worth noting some key metrics and insights from InvestingPro that could be of interest to investors. The company’s dedication to shareholder returns is mirrored in W. P. Carey Inc. (NYSE:), which has not only raised its dividend for 12 consecutive years but has also maintained dividend payments for 26 consecutive years, showcasing a strong commitment to consistent shareholder value.

InvestingPro Data indicates WPC’s robust financial health, with a market capitalization of $14.2 billion and a P/E Ratio of 17.92, suggesting a valuation that may appeal to value investors. The company’s gross profit margin stands at an impressive 92.39%, reflecting efficient operations and a strong market position.

Adding to the financial strength, two InvestingPro Tips highlight WPC’s high earnings quality with free cash flow exceeding net income, and analysts’ anticipation of sales growth in the current year. These factors could be particularly relevant for CVS Health investors considering the company’s focus on profitability and growth.

For those interested in deeper analytics and additional insights, InvestingPro offers more tips on WPC, which could provide valuable context for investors comparing industry peers. The InvestingPro subscription is now on a special Cyber Monday sale with a discount of up to 60%. Plus, use coupon code sfy23 to get an additional 10% off a 2-year InvestingPro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.